BEAM
Price
$18.76
Change
+$2.45 (+15.02%)
Updated
Sep 3 closing price
Capitalization
1.9B
67 days until earnings call
IRON
Price
$61.59
Change
+$0.19 (+0.31%)
Updated
Sep 3 closing price
Capitalization
2.14B
63 days until earnings call
Interact to see
Advertisement

BEAM vs IRON

Header iconBEAM vs IRON Comparison
Open Charts BEAM vs IRONBanner chart's image
Beam Therapeutics
Price$18.76
Change+$2.45 (+15.02%)
Volume$8.6M
Capitalization1.9B
Disc Medicine
Price$61.59
Change+$0.19 (+0.31%)
Volume$325.47K
Capitalization2.14B
BEAM vs IRON Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. IRON commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and IRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (BEAM: $18.76 vs. IRON: $61.59)
Brand notoriety: BEAM and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 345% vs. IRON: 100%
Market capitalization -- BEAM: $1.9B vs. IRON: $2.14B
BEAM [@Biotechnology] is valued at $1.9B. IRON’s [@Biotechnology] market capitalization is $2.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while IRON’s TA Score has 7 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • IRON’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, IRON is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +11.27% price change this week, while IRON (@Biotechnology) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.15B) has a higher market cap than BEAM($1.9B). IRON YTD gains are higher at: -2.855 vs. BEAM (-24.355). IRON has higher annual earnings (EBITDA): -142.42M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. IRON (650M). IRON has less debt than BEAM: IRON (30.9M) vs BEAM (155M). BEAM has higher revenues than IRON: BEAM (60.3M) vs IRON (0).
BEAMIRONBEAM / IRON
Capitalization1.9B2.15B88%
EBITDA-414.33M-142.42M291%
Gain YTD-24.355-2.855853%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B650M177%
Total Debt155M30.9M502%
TECHNICAL ANALYSIS
Technical Analysis
BEAMIRON
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDLAX11.830.12
+1.02%
Columbia Disciplined Growth A
AGWUX65.700.63
+0.97%
American Century Growth R5
CCTRX13.38N/A
N/A
Columbia Sm Cp Val and Inflection R
TFEQX12.41-0.01
-0.08%
Templeton Instl Intl Eq Ser Primary
FSGRX22.93-0.11
-0.48%
Franklin Small Cap Growth A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been loosely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+15.02%
CRSP - BEAM
66%
Loosely correlated
+0.61%
NTLA - BEAM
64%
Loosely correlated
+2.72%
RXRX - BEAM
62%
Loosely correlated
-0.64%
SYRE - BEAM
58%
Loosely correlated
+1.08%
DNLI - BEAM
56%
Loosely correlated
-0.91%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.31%
SYRE - IRON
53%
Loosely correlated
+1.08%
CGON - IRON
51%
Loosely correlated
+4.41%
IDYA - IRON
51%
Loosely correlated
+1.10%
CRNX - IRON
50%
Loosely correlated
+4.05%
BEAM - IRON
50%
Loosely correlated
+15.02%
More